Akting and cycling: a tale of the pituitary.
Pituitary tumours are characterized by a series of phenotypic abnormalities, but the molecular nature of the underlying defects has proved peculiarly intractable. Oncogenes and tumour suppressor genes involved in other tumours do not appear to play a major role in the pathogenesis of pituitary tumou...
Main Authors: | Grossman, AB, Korbonits, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Enhanced protein kinase B/Akt signalling in pituitary tumours.
by: Musat, M, et al.
Published: (2005) -
Cell cycle dysregulation in pituitary oncogenesis.
by: Muşat, M, et al.
Published: (2004) -
Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
by: Cakir, M, et al.
Published: (2009) -
STOP AKTING TO TREAT ENDOCRINE TUMOURS
by: Musat, M, et al.
Published: (2009) -
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
by: Dworakowska, D, et al.
Published: (2009)